Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 532

    1.

    Delayed-onset heparin-induced thrombocytopenia and thrombosis.

    Warkentin TE, Kelton JG.

    Ann Intern Med. 2001 Oct 2;135(7):502-6.PMID: 11578153 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Delayed-onset heparin-induced thrombocytopenia and thrombosis.

    [No authors listed]

    Ann Intern Med. 2001 Oct 2;135(7):S-45. No abstract available. PMID: 11596575 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Delayed-onset heparin-induced thrombocytopenia.

    Smythe MA, Stephens JL, Mattson JC.

    Ann Emerg Med. 2005 Apr;45(4):417-9.PMID: 15795722 [PubMed - indexed for MEDLINE]Related articles

    4.

    Delayed-onset heparin-induced thrombocytopenia.

    Rice L, Attisha WK, Drexler A, Francis JL.

    Ann Intern Med. 2002 Feb 5;136(3):210-5.PMID: 11827497 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Temporal aspects of heparin-induced thrombocytopenia.

    Warkentin TE, Kelton JG.

    N Engl J Med. 2001 Apr 26;344(17):1286-92.PMID: 11320387 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.

    Mattioli AV, Bonetti L, Sternieri S, Mattioli G.

    Ital Heart J. 2000 Jan;1(1):39-42.PMID: 10868921 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.

    Reilly MP, Taylor SM, Franklin C, Sachais BS, Cines DB, Williams KJ, McKenzie SE.

    J Thromb Haemost. 2006 Dec;4(12):2687-94. Epub 2006 Sep 8.PMID: 16961586 [PubMed - indexed for MEDLINE]Related articles

    8.

    New approaches to the diagnosis of heparin-induced thrombocytopenia.

    Warkentin TE.

    Chest. 2005 Feb;127(2 Suppl):35S-45S. Review.PMID: 15706029 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.

    Amiral J, Wolf M, Fischer A, Boyer-Neumann C, Vissac A, Meyer D.

    Br J Haematol. 1996 Mar;92(4):954-9.PMID: 8616093 [PubMed - indexed for MEDLINE]Related articles

    10.

    Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.

    Denomme GA, Warkentin TE, Horsewood P, Sheppard JA, Warner MN, Kelton JG.

    J Lab Clin Med. 1997 Sep;130(3):278-84.PMID: 9341987 [PubMed - indexed for MEDLINE]Related articles

    11.

    Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.

    Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A.

    Eur J Haematol. 2006 May;76(5):420-6. Epub 2006 Feb 6.PMID: 16466367 [PubMed - indexed for MEDLINE]Related articles

    12.

    Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.

    Fabris F, Luzzatto G, Soini B, Ramon R, Scandellari R, Randi ML, Girolami A.

    J Intern Med. 2002 Aug;252(2):149-54.PMID: 12190890 [PubMed - indexed for MEDLINE]Related articles

    13.

    A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia.

    Warkentin TE, Makris M, Jay RM, Kelton JG.

    Am J Med. 2008 Jul;121(7):632-6.PMID: 18589060 [PubMed - indexed for MEDLINE]Related articles

    14.

    Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.

    Alberio L, Kimmerle S, Baumann A, Taleghani BM, Biasiutti FD, Lämmle B.

    Am J Med. 2003 May;114(7):528-36.PMID: 12753876 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impact of the patient population on the risk for heparin-induced thrombocytopenia.

    Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG.

    Blood. 2000 Sep 1;96(5):1703-8.PMID: 10961867 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.

    Mattioli AV, Bonetti L, Zennaro M, Ambrosio G, Mattioli G.

    Am Heart J. 2009 Mar;157(3):589-95. Epub 2009 Jan 13.PMID: 19249435 [PubMed - indexed for MEDLINE]Related articles

    17.

    Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.

    Ahmad S, Walenga JM, Jeske WP, Cella G, Fareed J.

    Clin Appl Thromb Hemost. 1999 Oct;5 Suppl 1:S32-7.PMID: 10726034 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy]

    Folwaczny EK, Stürmer KM.

    Chirurg. 2002 Dec;73(12):1197-203. German. PMID: 12491049 [PubMed - indexed for MEDLINE]Related articles

    19.

    Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.

    Koster A, Dyke CM, Aldea G, Smedira NG, McCarthy HL 2nd, Aronson S, Hetzer R, Avery E, Spiess B, Lincoff AM.

    Ann Thorac Surg. 2007 Feb;83(2):572-7.PMID: 17257990 [PubMed - indexed for MEDLINE]Related articles

    20.

    Clinical presentation, temporal relationship, and outcome in thirty-three patients with type 2 heparin-induced thrombocytopenia after cardiotomy.

    Wan C, Warner M, De Varennes B, Ergina P, Cecere R, Lachapelle K.

    Ann Thorac Surg. 2006 Jul;82(1):21-6.PMID: 16798180 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data